Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA008531-04
Application #
2121049
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1993-09-30
Project End
1998-07-31
Budget Start
1996-08-01
Budget End
1997-07-31
Support Year
4
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Seattle Biomedical Research Institute
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98109
Feng, Xianqi; Fandrick, Keith; Johnson, Robert et al. (2003) Syntheses of 3-carbomethoxy-4-(aryl)piperidines and in vitro and in vivo pharmacological evaluation: identification of inhibitors of the human dopamine transporter. Bioorg Med Chem 11:775-80
Cashman, J R; Berkman, C E; Underiner, G E (2000) Catalytic antibodies that hydrolyze (-)-cocaine obtained by a high-throughput procedure. J Pharmacol Exp Ther 293:952-61
Xie, W; Altamirano, C V; Bartels, C F et al. (1999) An improved cocaine hydrolase: the A328Y mutant of human butyrylcholinesterase is 4-fold more efficient. Mol Pharmacol 55:83-91
Cashman, J R; Berkman, C E; Underiner, G et al. (1998) Cocaine benzoyl thioester: synthesis, kinetics of base hydrolysis, and application to the assay of cocaine esterases. Chem Res Toxicol 11:895-901
Berkman, C E; Underiner, G E; Cashman, J R (1997) Stereoselective inhibition of human butyrylcholinesterase by phosphonothiolate analogs of (+)- and (-)-cocaine. Biochem Pharmacol 54:1261-6
Lin, J; Cashman, J R (1997) Detoxication of tyramine by the flavin-containing monooxygenase: stereoselective formation of the trans oxime. Chem Res Toxicol 10:842-52
Cashman, J R (1997) Biocatalysts in detoxication of drugs of abuse. NIDA Res Monogr 173:225-58
Cashman, J R; Perotti, B Y; Berkman, C E et al. (1996) Pharmacokinetics and molecular detoxication. Environ Health Perspect 104 Suppl 1:23-40